Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study

General Info

Geography

Norway (NOR)

Coverage type

Country

Time period covered

January, 2020 - December, 2020

Data type

Scientific literature

Keywords

Breathing difficulty, COVID-19, Cognitive impairment, Disease outbreaks, Fatigue, Headache, Long COVID

Citation

Authors

Fjelltveit EB, Blomberg B, Kuwelker K, Zhou F, Onyango TB, Brokstad KA, Elyanow R, Kaplan IM, Tøndel C, Mohn KGI, Özgümüş T, Cox RJ, Langeland N, Bergen COVID-19 Research Group

Journal

Clin Infect Dis

Pages

e60-e70

Publication year

2023

Suggested citation

Fjelltveit EB, Blomberg B, Kuwelker K, Zhou F, Onyango TB, Brokstad KA, Elyanow R, Kaplan IM, Tøndel C, Mohn KGI, Özgümüş T, Cox RJ, Langeland N, Bergen COVID-19 Research Group. Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. Clin Infect Dis. 2023; 76(3): e60-e70.